Peter Gibson works as a doctor who cares for people with respiratory diseases and as a clinical scientist investigating the mechanisms and treatment of asthma, COPD, cough, and other airway disorders. He is a concept leader who has developed innovative approaches around inflammatory subtypes of asthma and cough; airway biomarkers; neurogenic mechanisms, laryngeal dysfunction and related treatments for refractory cough; multidimensional assessment and management of complex airway disorders such as severe asthma, airways diseases in the elderly, and asthma in pregnant women. Peter's research metrics record a H index of 80 (Web of Science), >670 published articles and >$40 Million in research funding. He has had continuous research grant funding from NHMRC, Asthma NSW, MSRP, Cooperative Research Centre for Asthma and Airways and successful NHMRC CRE programmes. Recognised as Australia’s top pulmonary researcher (The Australian, Research Report 2019) Peter’s peers have awarded him several research honours, including the 2018 ERS Gold Medal in Asthma, and elected him as the president of the Thoracic Society of Australia and New Zealand (2015-6). His research, clinical practice, and participation in guideline panels serve to bring research developments into focus as effective health care interventions that improve the health of people suffering from breathing disorders.